DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Bank of Montreal Can

Bank of Montreal Can lessened its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 2.1% during the fourth quarter, Holdings Channel reports. The firm owned 283,029 shares of the medical instruments supplier’s stock after selling 6,073 shares during the period. Bank of Montreal Can’s holdings in DENTSPLY SIRONA were worth $5,372,000 at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in the stock. UMB Bank n.a. boosted its holdings in DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 564 shares during the last quarter. MML Investors Services LLC lifted its stake in shares of DENTSPLY SIRONA by 2.1% in the 3rd quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock valued at $803,000 after purchasing an additional 620 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of DENTSPLY SIRONA by 10.9% during the 4th quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier’s stock worth $137,000 after purchasing an additional 707 shares during the period. Federated Hermes Inc. increased its position in DENTSPLY SIRONA by 0.5% during the 4th quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier’s stock worth $3,213,000 after purchasing an additional 915 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB raised its holdings in DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after buying an additional 1,232 shares during the period. 95.70% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $30.00 to $20.00 in a research note on Thursday, January 23rd. Evercore ISI reiterated an “in-line” rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Barrington Research reduced their price objective on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. Morgan Stanley lowered their target price on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a research note on Tuesday, December 17th. Finally, StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Twelve research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $23.33.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $13.08 on Tuesday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock has a market capitalization of $2.60 billion, a price-to-earnings ratio of -6.32, a PEG ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $31.75. The company’s 50-day simple moving average is $16.09 and its 200-day simple moving average is $19.01.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.89%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -14.07%.

Insiders Place Their Bets

In related news, Director Gregory T. Lucier bought 15,142 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.52% of the stock is owned by corporate insiders.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.